Page last updated: 2024-10-30

mesalamine and Dermatomyositis, Adult Type

mesalamine has been researched along with Dermatomyositis, Adult Type in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"Infliximab can improve DM in the treatment of ulcerative colitis."1.56Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report. ( Chen, L; Gu, GL; Han, LC; Huang, BB; Li, SQ; Liu, GF; Lv, XD; Lv, XP; Wang, HQ; Zhan, LL, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Huang, BB1
Han, LC1
Liu, GF1
Lv, XD1
Gu, GL1
Li, SQ1
Chen, L1
Wang, HQ1
Zhan, LL1
Lv, XP1

Other Studies

1 other study available for mesalamine and Dermatomyositis, Adult Type

ArticleYear
Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report.
    World journal of gastroenterology, 2020, Dec-14, Volume: 26, Issue:46

    Topics: Colitis, Ulcerative; Dermatomyositis; Female; Humans; Infliximab; Mesalamine; Middle Aged

2020